Egypt opens first phase of vaccine city, launches local pneumococcal vaccine production

Egypt has opened the first phase of its Vaccines and Biotechnology City and launched technology transfer to produce the pneumococcal vaccine locally.

• Egypt opened the first phase of the Vaccines and Biotechnology City in Ismailia, spanning 115,000 square meters and housing human and veterinary vaccine plants.
• Health Minister Khaled Abdel Ghaffar launched the technology transfer to manufacture the PCV13 pneumococcal vaccine, the first locally produced vaccine of its kind.
• An agreement was signed to export the vaccine to 19 countries in Africa and the Middle East.
• Assistant Health Minister Hossam Abdel Ghaffar said investment will reach 12 billion Egyptian pounds by 2030, with 140 million human vaccine doses planned annually.